ADAG adagene.com: היקף יתרות המזומנים של החברה

Adagene is actively expanding by developing safe antibodies to combat cancer. The cash position demonstrates current liquidity, where 0.13 determines the current value of this metric. The brand's high authority is based on AI-driven protein engineering technologies. However, the lack of sales leaves the company dependent on investor capital, rendering its cash flows unstable.
פילוחים אנליטיים של חברת Adagene

This metric measures the aggregate of highly liquid assets, determining the company's ability to maintain operational activities and invest in growth without incurring external debt. Analyzing the enterprise's cash reserve allows for an assessment of Adagene (ADAG) resilience to geopolitical restrictions in the biotechnology sector, which could slow cross-border research and necessitate additional expenditures to ensure biosafety.